Current through the 2023 Regular Session
Section 50-32-231 - Criteria for placement of drug in Schedule VThe board shall place a drug in Schedule V if it finds that:
(1) the drug has low potential for abuse relative to the controlled drugs listed in Schedule IV;(2) the drug has currently accepted medical use in treatment in the United States; and(3) the drug has limited physical dependence or psychological dependence liability relative to the dangerous drugs listed in Schedule IV.En. Sec. 12, Ch. 412, L. 1973; R.C.M. 1947, 54-312.